These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11353731)

  • 1. Abnormal axonal inward rectifier in streptozocin-induced experimental diabetic neuropathy.
    Yang Q; Kaji R; Takagi T; Kohara N; Murase N; Yamada Y; Seino Y; Bostock H
    Brain; 2001 Jun; 124(Pt 6):1149-55. PubMed ID: 11353731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats.
    Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T
    Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An early diagnostic tool for diabetic neuropathy: conduction velocity distribution.
    Tuncer S; Dalkilic N; Esen HH; Avunduk MC
    Muscle Nerve; 2011 Feb; 43(2):237-44. PubMed ID: 21254089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral nerve structure and function in experimental diabetes.
    Sharma AK; Thomas PK
    J Neurol Sci; 1974 Sep; 23(1):1-15. PubMed ID: 4277605
    [No Abstract]   [Full Text] [Related]  

  • 6. Function of the hyperpolarization-activated inward rectification in nonmyelinated peripheral rat and human axons.
    Grafe P; Quasthoff S; Grosskreutz J; Alzheimer C
    J Neurophysiol; 1997 Jan; 77(1):421-6. PubMed ID: 9120582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The axonopathy of diabetic neuropathy.
    Sidenius P
    Diabetes; 1982 Apr; 31(4 Pt 1):356-63. PubMed ID: 6759251
    [No Abstract]   [Full Text] [Related]  

  • 8. Accelerated diabetic neuropathy in axons without neurofilaments.
    Zochodne DW; Sun HS; Cheng C; Eyer J
    Brain; 2004 Oct; 127(Pt 10):2193-200. PubMed ID: 15289271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal persistent Na+ currents in human diabetic nerves estimated by the technique of latent addition.
    Misawa S; Kuwabara S; Kanai K; Tamura N; Nakata M; Ogawara K; Yagui K; Hattori T
    Clin Neurophysiol; 2006 Apr; 117(4):815-20. PubMed ID: 16495151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block.
    Kiernan MC; Guglielmi JM; Kaji R; Murray NM; Bostock H
    Brain; 2002 Mar; 125(Pt 3):664-75. PubMed ID: 11872621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of maturation on nerve excitability in an experimental model of threshold electrotonus.
    Yang Q; Kaji R; Hirota N; Kojima Y; Takagi T; Kohara N; Kimura J; Shibasaki H; Bostock H
    Muscle Nerve; 2000 Apr; 23(4):498-506. PubMed ID: 10716759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve electrophysiological changes in rats with early induced diabetes.
    Tarhzaoui K; Behar A; Lestrade RA; Hort-Legrand C; Cohen-Boulakia FE; Valensi PE
    Acta Physiol Hung; 2008 Jun; 95(2):195-208. PubMed ID: 18642759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beraprost sodium, a prostacyclin analogue, on tail flick response in two models of diabetic-neuropathy in rats and its mechanism.
    Ueno Y; Koike H; Annoh S; Nishio S
    Life Sci; 1996; 59(9):PL105-10. PubMed ID: 8761032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does diabetes mellitus target motor neurons?
    Ramji N; Toth C; Kennedy J; Zochodne DW
    Neurobiol Dis; 2007 May; 26(2):301-11. PubMed ID: 17337195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.
    Sung JY; Tani J; Chang TS; Lin CS
    PLoS One; 2017; 12(2):e0171223. PubMed ID: 28182728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal axonal inward rectification in diabetic neuropathy.
    Horn S; Quasthoff S; Grafe P; Bostock H; Renner R; Schrank B
    Muscle Nerve; 1996 Oct; 19(10):1268-75. PubMed ID: 8808652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve excitability and structural changes in myelinated axons from diabetic mice.
    Campero M; Ezquer M; Ezquer F
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):485-91. PubMed ID: 26285066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.